Breast Cancer

The Pharmacy Times® Breast Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancers that occur in the breast, including invasive ductal carcinoma, invasive lobular carcinoma, and less common forms of the disease.

Latest News

Computer Screen in Hospital Radiology Room: Woman Standing Undergoing Mammography Screening Procedure. Screen Showing the Mammogram Scans of Dense Breast Tissues - Image credit: Gorodenkoff | stock.adobe.com
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer

September 2nd 2025

Abemaciclib significantly enhances overall survival in high-risk HR+, HER2- early breast cancer, establishing a new standard of care.

Breast cancer and SERDs -- Image credit: Phongsakorn | stock.adobe.com
Oral SERDs in Breast Cancer: Imulnestrant and Elacestrant

August 27th 2025

In the hospital, the patient undergoes a screening procedure for a mammogram, which is performed by a mammogram. A modern technologically advanced clinic with professional doctors. Image Credit: Valerii Apetroaiei | stock.adobe.com
Suppression of JNK Pathway Drives Resistance to Endocrine and CDK4/6 Therapy in ER-Positive Breast Cancer

August 26th 2025

Ambulatory chemotherapy | Image Credit: RFBSIP | stock.adobe.com
Limited Benefit of Adjuvant Chemotherapy in Older Women With HR-Positive, HER2-Negative Breast Cancer

August 22nd 2025

Selection Considerations for Abemaciclib Versus Ribociclib in Early HR+/HER2- Breast Cancer: Efficacy, Safety, and Long-Term Outcomes
Selection Considerations for Abemaciclib Versus Ribociclib in Early HR+/HER2- Breast Cancer: Efficacy, Safety, and Long-Term Outcomes

August 17th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.